Braxia Scientific Corp C.BRAX

Alternate Symbol(s): BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.

CSE:BRAX - Post by User

Braxia Scientific Corp > Psychedelics Present Lucrative Opportunities For Investors

<< Previous

Bullboard Posts

Next >>

Comment by cautiousguyon Dec 30, 2021 1:26am

125 Views

Post# 34269870

RE:RE:Psychedelics Present Lucrative Opportunities For Investors

Korcan wrote:
Great article. Thanks for posting.
2022 is a new year.
Psychedelics will move along nicely.
BRAX is starting below a dime and should excel.

OH! So the shorting "conspiracy" is no longer a problem? How did I let that happen?

newcoin wrote: https://psych.global/psychedelic-healthcare-in-2021/